ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

NIH Grants: R29 Awards No Longer Accepted After June; NIH To Increase R01s.

December 5, 1997

NCAB Okays Concepts For ICI Contract Support, Databases

October 11, 1991

NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015

February 14, 2003

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000